LNC THERAPEUTICS
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases. All projects encompass fundamental research, preclinical studies and clinical trials. Backed by leading venture capital investors, such as Seventure Partners (with the microbiome dedicated vehicle Health for Life Capital) and Family Offices, the company cultivates worldwide collaborations with renowned medical experts to ensure the highest level of standards in the development of innovative drugs. With a total of € 16.5 million raised so far including € 1.5 million grants from French BPI and Aquitaine Region, LNC Therapeutics will pursue its research programs to bring the next generation approach to treat obesity and cardiometabolic diseases.
LNC THERAPEUTICS
Industry:
Biopharma Biotechnology Life Science
Founded:
2010-01-01
Address:
Bordeaux, Aquitaine, France
Country:
France
Website Url:
http://www.lnctherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+33557831503
Email Addresses:
[email protected]
Total Funding:
19.09 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx Amazon Facebook Sharer CloudFront Google Adsense AWS Global Accelerator
Similar Organizations
The Brkfst Club
The Brkfst Club focuses on gathering like-minded individuals to invest in ground breaking ideas.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
Seventure Partners
Seventure Partners investment in Venture Round - LNC Therapeutics
Seventure Partners
Seventure Partners investment in Series C - LNC Therapeutics
AQUITI Gestion
AQUITI Gestion investment in Series B - LNC Therapeutics
Seventure Partners
Seventure Partners investment in Series B - LNC Therapeutics
Blackstone Credit
Blackstone Credit investment in Series B - LNC Therapeutics
IRDI
IRDI investment in Series B - LNC Therapeutics
Official Site Inspections
http://www.lnctherapeutics.com Semrush global rank: 9.57 M Semrush visits lastest month: 139
- Host name: lb-182-253.above.com
- IP address: 103.224.182.253
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
More informations about "LNC Therapeutics"
LNC Therapeutics - VentureRadar
LNC Therapeutics is a French biotech company specializing in the research and development of therapeutic innovations harnessing the potential of the gut microbiome. The company is …See details»
LNC Therapeutics - Crunchbase Company Profile & Funding
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases. All projects encompass fundamental research, preclinical studies …See details»
YSOPIA Bioscience (previously LNC Therapeutics) - VentureRadar
LNC Therapeutics is a French biotech company specializing in the research and development of therapeutic innovations harnessing the potential of the gut microbiome. The company is …See details»
YSOPIA Bioscience - Craft
YSOPIA Bioscience (formerly known as LNC Therapeutics) is a biotech company specializing in gut microbiome-based drug discovery. It is engaged in exploring and optimizing single …See details»
LNC Therapeutics - Funding, Financials, Valuation & Investors
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases.See details»
LNC Therapeutics becomes YSOPIA Bioscience
Oct 1, 2020 · French biotech firm LNC Therapeutics is to change its name to YSOPIA Bioscience in a move designed to reflect a change in research direction towards drugs that harness the gut microbiome’s potential.See details»
www.lnctherapeutics.com
Www.lnctherapeutics.comSee details»
LNC Therapeutics - Contacts, Employees, Board Members
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases.See details»
Biotech focus: LNC to shift away from nutrition as it eyes promise …
Jun 11, 2018 · The new CEO of French microbiome pioneer LNC Therapeutics says the company is at the start of a transition away from nutrition and towards biotechnologies and drug-based …See details»
LNC Therapeutics - Company info. interviews, news
Founded in 2010, LNC Therapeutics is a French biotech company specialized in gut microbiome-based drug discovery. All of the company's projects include basic research, preclinical research and clinical trials.See details»
LNC Therapeutics Receives FDA Investigational New …
Sep 14, 2020 · With an active IND and the clinical c-GMP batch available, LNC Therapeutics is planning to assess the safety and tolerability of Xla1 in adults with obesity and metabolic abnormalities in a Phase 1 clinical trial in the US. …See details»
LNC Therapeutics Company Information - Funding, Investors, and …
Get information on funding, investors, industries, and more for LNC Therapeutics. See LNC Therapeutics company profile and funding data.See details»
LNC Therapeutics (Exclusive Worldwide License For Therapeutic ...
Information on acquisition, funding, investors, and executives for LNC Therapeutics (Exclusive Worldwide License For Therapeutic Application Of Christensenella). Use the PitchBook …See details»
LNC Therapeutics - VentureRadar
LNC Therapeutics is a French biotech company specializing in the research and development of therapeutic innovations harnessing the potential of the... ... Find out more about LNC …See details»
LNC Therapeutics develops Christensenella therapy for mood
Apr 17, 2020 · French biotech firm LNC Therapeutics is to enter into a licence agreement with the University of Valencia for a patent outlining the Christensenella gut bacteria's role in …See details»
LNC Therapeutics Chooses Luina Bio for the Development and …
LNC Therapeutics, a French biotech company specializing in gut microbiome-based drug discovery have signed a manufacturing agreement with Luina Bio as the CDMO responsible …See details»
LNC Therapeutics Licenses Microbiome Therapeutic to Treat Mood …
Apr 17, 2020 · The French microbiome biotech LNC Therapeutics has entered into a licensing agreement to use a specific strain of gut bacteria for the treatment of mood disorders such as …See details»
LNC targets human trials this year as it steps up licencing and …
May 7, 2020 · French biotech LNC Therapeutics says it will launch the first ever in-human trials to dose with a single strain of Christensenella before the end of 2020, as the company looks to …See details»
LNC Therapeutics | VentureRadar
LNC Therapeutics is a French biotech company specializing in the research and development of therapeutic innovations harnessing the potential of the gut microbiome. The company is …See details»
LNC Therapeutics Acquires Exclusive License for the …
Oct 17, 2018 · LNC Therapeutics, a French biotech company specializing in gut microbiome-based drug discovery announced that it has signed an exclusive license agreement with …See details»